The downregulation of EPHB2, involved in cell cycle processes, and LEFTY1, involved in intestinal mucosal immunity and TGF-β signaling, is a common feature also observed in colorectal cancers and Crohn’s disease, respectively [64, 65]. Here, EPHB2 is linked to Crohn disease.